The 23rd Management Committee Meeting of the International Medical Device Regulators Forum (IMDRF) took place in…
Category: Regulatory Affairs
Global updates on medical device regulation and quality.
FDA Targets Misleading Drug Ads with New Compliance Initiative
The U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS)…
FDA Highlights Safety Alert for Abiomed’s Impella Controllers Due to Purge Retainer Issue
The FDA has issued an early alert regarding a significant safety concern with Abiomed’s Automated Impella…
Critical Updates: Field Safety Notices for Medical Devices Issued from 5 to 9 May 2025
Medical device users and healthcare teams should note the publication of new Field Safety Notices (FSNs)…
FDA Launches Guidance to Advance Non-Opioid Chronic Pain Solutions and Battle Opioid Misuse
The U.S. Food and Drug Administration (FDA) has announced a major step in addressing the opioid…
Key Learnings from the 23rd IMDRF Workshop: Enhancing Post-Market Surveillance in Medical Device Regulation
On September 30, 2025, the International Medical Device Regulators Forum (IMDRF), together with DITTA and GMTA,…
Critical Update: 3M Issues Urgent Labeling Correction for Ranger Blood and Fluid Warming Systems
The 3M Company has announced a critical correction for its Ranger Blood and Fluid Warming Systems,…
Important Regulatory Notification: Patient Safety Gaps Identified in Ipca Laboratories UK Ltd PILs
On September 30, 2025, Ipca Laboratories UK Ltd issued an urgent notification to the Medicines and…
U.S. Agencies Execute Record Seizure of Unauthorized E-Cigarettes Worth $86.5 Million
The U.S. Department of Health and Human Services (HHS) and U.S. Customs and Border Protection (CBP)…
IMDRF Releases Progress Update on Strategic Plan 2021-2025
The International Medical Device Regulators Forum (IMDRF) has provided a detailed progress report on its Strategic…